| Patent Number |
Title Of Patent |
Date Issued |
| 7556935 |
Induction of apoptosis by cellular stress |
July 7, 2009 |
| The invention provides methods of screening to identify compounds that modulate the ability of a protein to translocate to the mitochondria when a cell is subjected to cellular stress. Such compounds can be useful to modulate the level of apoptosis in a cell. For example, compounds i |
| 7553616 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
June 30, 2009 |
| The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy |
| 7550260 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
June 23, 2009 |
| The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy |
| 7550258 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
June 23, 2009 |
| The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy |
| 7329489 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
February 12, 2008 |
| The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy |
| 7285573 |
Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
October 23, 2007 |
| The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of di |
| 7186754 |
Use of creatine or creatine compounds for skin preservation |
March 6, 2007 |
| The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates |
| 7118862 |
Induction of apoptosis by cellular stress |
October 10, 2006 |
| The invention provides methods of screening to identify compounds that modulate the ability of a protein to translocate to the mitochondria when a cell is subjected to cellular stress. Such compounds can be useful to modulate the level of apoptosis in a cell. For example, compounds i |
| 7005255 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
February 28, 2006 |
| The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy |
| 6720188 |
Methods and kits for the detection of arginine compounds |
April 13, 2004 |
| Methods and kits for determine arginine compounds are discussed. The methods and kits of the invention can be used for the diagnosis of arginine compound associated disorders. |
| 6706764 |
Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
March 16, 2004 |
| The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of di |
| 6566086 |
Diagnostic kit for detecting creatine levels |
May 20, 2003 |
| Methods for the detection of creatine compound levels in body fluid samples are discussed. Portable kits capable of determining creatine levels using non-invasive and visually detectable methods are also included. |
| 6288124 |
Methods of inhibiting undesirable cell growth using an aminoguanidine compound |
September 11, 2001 |
| The present invention provides for the use of aminoguanidines for prophylactic and/or therapeutic treatments of undesirable cell growth, e.g. tumors. The present invention provides methods of using aminoguanidines, optionally in combination with a hyperplastic inhibitory agent, to in |
| 6242491 |
Use of creatine or creatine compounds for skin preservation |
June 5, 2001 |
| The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates as e |
| 6169115 |
Use of aminoguanidine analogs for the treatment of diseases of the nervous system |
January 2, 2001 |
| The present invention relates to the use of aminoguanidine compounds for treating diseases of the nervous system. Aminoguanidine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripher |
| 6075031 |
Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glu |
June 13, 2000 |
| The present invention relates to the use of creatine compounds including cyclocreatine and creatine phosphate for treating or preventing a metabolic disorder consisting of hyperglycemia, insulin dependent diabetes mellitus, impaired glucose tolerance, hyperinsulinemia, insulin insens |
| 5998457 |
Creatine analogues for treatment of obesity |
December 7, 1999 |
| The present invention relates to the use of creatine compounds for treating or preventing a metabolic disorder related to body weight control such as obesity, and it's associated diseases in a patient experiencing said disorder. The creatine compounds which can be used in the present met |
| 5676978 |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound an |
October 14, 1997 |
| The present invention provides for the use of creatine compounds and hyperplastic inhibitory agents for prophylactic and/or therapeutic treatments of undesirable cell growth, e.g. tumors. The present invention provides methods of using creatine compounds, in combination with a hyperp |
